Ugne Balaseviciute

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Cardiac Surgery

Top Venues

Molecular cancer therapeutics

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute, Roser Pinyol, Carla Montironi, Philipp K Haber, Álvaro Del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas K Akers, Catherine E Willoughby, Judit Peix, Miguel Torres-Martin, Marc Puigvehí, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincenzo Mazzaferro, Ernesto Guccione, Daniela Sia, Carolina Armengol, Josep M Llovet
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma. Molecular cancer therapeutics (2023)
Jordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute, Roser Pinyol, Carla Montironi, Philipp K Haber, Álvaro Del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas K Akers, Catherine E Willoughby, Judit Peix, Miguel Torres-Martin, Marc Puigvehí, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincenzo Mazzaferro, Ernesto Guccione, Daniela Sia, Carolina Armengol, Josep M Llovet
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma. Molecular cancer therapeutics (2023)
Laura Torrens, Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K Haber, Miho Maeda, Ugne Balaseviciute, Catherine E Willoughby, Jordi Abril-Fornaguera, Marta Piqué-Gili, Miguel Torres-Martin, Judit Peix, Daniel Geh, Erik Ramon-Gil, Behnam Saberi, Scott L Friedman, Derek A Mann, Daniela Sia, Josep M Llovet
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology (Baltimore, Md.) 74 (5) (2021)